Published ahead of print on November 30, 2006, doi:10.1164/rccm.200605-665OC
American Journal of Respiratory and Critical Care Medicine Vol 175. pp. 480-489, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200605-665OC
Impact of Intensive Insulin Therapy on Neuromuscular Complications and Ventilator Dependency in the Medical Intensive Care Unit
Greet Hermans1,
Alexander Wilmer1,
Wouter Meersseman1,
Ilse Milants2,
Pieter J. Wouters2,
Herman Bobbaers1,
Frans Bruyninckx3 and
Greet Van den Berghe2
1 Medical Intensive Care Unit, Department of Internal Medicine, 2 Department of Intensive Care Medicine, and 3 Department of Physical Medicine and Rehabilitation, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium
Correspondence and requests for reprints should be addressed to Prof. G. Van den Berghe, M.D., Ph.D., Department of Intensive Care Medicine, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. E-mail: greta.vandenberghe{at}med.kuleuven.be
Rationale: Critical illness polyneuropathy/myopathy causes limb and respiratory muscle weakness, prolongs mechanical ventilation, and extends hospitalization of intensive care patients. Besides controlling risk factors, no specific prevention or treatment exists. Recently, intensive insulin therapy prevented critical illness polyneuropathy in a surgical intensive care unit.
Objectives: To investigate the impact of intensive insulin therapy on polyneuropathy/myopathy and treatment with prolonged mechanical ventilation in medical patients in the intensive care unit for at least 7 days.
Methods: This was a prospectively planned subanalysis of a randomized controlled trial evaluating the effect of intensive insulin versus conventional therapy on morbidity and mortality in critically ill medical patients. All patients who were still in intensive care on Day 7 were screened weekly by electroneuromyography. The effect of intensive insulin therapy on critical illness polyneuropathy/myopathy and the relationship with duration of mechanical ventilation were assessed.
Measurements and Main Results: Independent of risk factors, intensive insulin therapy reduced incidence of critical illness polyneuropathy/myopathy (107/212 [50.5%] to 81/208 [38.9%], p = 0.02). Treatment with prolonged ( 14 d) mechanical ventilation was reduced from 99 of 212 (46.7%) to 72 of 208 (34.6%) (p = 0.01). This was statistically only partially explained by prevention of critical illness polyneuropathy/myopathy.
Conclusion: In a subset of medical patients in the intensive care unit for at least 7 days, enrolled in a randomized controlled trial of intensive insulin therapy, those assigned to intensive insulin therapy had a reduced incidence of critical illness polyneuropathy/myopathy and were treated with prolonged mechanical ventilation less frequently.
Key Words: polyneuropathy blood glucose myopathy
| AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
Critical illness polyneuropathy/myopathy causes limb and respiratory muscle weakness, prolonged mechanical ventilation, and extended hospitalization. Besides controlling risk factors, no specific prevention or treatment exists.
What This Study Adds to the Field
Intensive insulin therapy prevents critical illness polyneuropathy in medical ICU patients and is associated with reduced requirements for prolonged mechanical ventilation.
|
Related articles in AJRCCM:
- Critical Illness Neuromyopathy: From Risk Factors to Prevention
- Bernard De Jonghe and Simon Finfer
AJRCCM 2007 175: 424-425.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
D. M. Needham
Mobilizing Patients in the Intensive Care Unit: Improving Neuromuscular Weakness and Physical Function
JAMA,
October 8, 2008;
300(14):
1685 - 1690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Ali, J. M. O'Brien Jr., S. P. Hoffmann, G. Phillips, A. Garland, J. C. W. Finley, K. Almoosa, R. Hejal, K. M. Wolf, S. Lemeshow, et al.
Acquired Weakness, Handgrip Strength, and Mortality in Critically Ill Patients
Am. J. Respir. Crit. Care Med.,
August 1, 2008;
178(3):
261 - 268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Fowler, N. K. J. Adhikari, D. C. Scales, W. L. Lee, and G. D. Rubenfeld
Update in Critical Care 2007
Am. J. Respir. Crit. Care Med.,
April 15, 2008;
177(8):
808 - 819.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hyzy, S. Huang, J. Myers, K. Flaherty, and F. Martinez
Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Chest,
November 1, 2007;
132(5):
1652 - 1658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Langouche, S. Vander Perre, P. J. Wouters, A. D'Hoore, T. K. Hansen, and G. Van den Berghe
Effect of Intensive Insulin Therapy on Insulin Sensitivity in the Critically Ill
J. Clin. Endocrinol. Metab.,
October 1, 2007;
92(10):
3890 - 3897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Vanhorebeek, L. Langouche, and G. Van den Berghe
Tight Blood Glucose Control With Insulin in the ICU: Facts and Controversies
Chest,
July 1, 2007;
132(1):
268 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. De Jonghe and S. Finfer
Critical Illness Neuromyopathy: From Risk Factors to Prevention
Am. J. Respir. Crit. Care Med.,
March 1, 2007;
175(5):
424 - 425.
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 American Thoracic Society
|
|
|